Hints and tips:
Showing results for BIO-MEDICAL APPLICATIONS OF INDIANA, INC.
Related Special Reports
...The New York-based drugmaker filed a trademark application in mid-April for a website and app providing medical information as well as mail-order pharmacy and telehealth services to US patients under the...
...Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to...
...The Medical Research Council has filed a patent application based on the latest work....
...Earlier this month, Biogen and Eisai delayed filing a regulatory application for a weekly subcutaneous injectable version of Leqembi after the FDA asked for three months of extra immune response data....
...the hybrid creation published in Nature Electronics on Monday Researchers from Indiana University Bloomington, the universities of Florida and Cincinnati, and Cincinnati Children’s Hospital Medical Center...
...Hacking Inc....
...Although click and bio-orthogonal chemistry are already used in practical applications, “the field is still in its early phase”, Bertozzi added....
...A version of this article was first published by Nikkei Asia on April 19 2023. ©2023 Nikkei Inc. All rights reserved....
...We haven’t built up the kinds of bio defences that we would need against the next pandemic. We don’t have the sort of bio-surveillance diagnostics, breakthroughs and medical countermeasures....
...Constructive Bio, as the start-up is called, is a spinout from the Medical Research Council’s Laboratory of Molecular Biology....
...Hillhouse InvestmentO: 7; L: 7; I: 7; Total: 21The private equity firm’s legal team worked with software developers to create an online portal combining several applications to help on day-to-day work, such...
...A few years ago, Suess set up a fund whose key investment themes include the therapeutic applications of cannabis after several of his clients asked about it....
...Weizmann project, has also started a company called Renewal Bio....
...In August an Indiana judge refused a request by 3M to halt thousands of personal injury claims involving alleged faulty earplugs following a bankruptcy filing by a subsidiary. 3M is appealing the judgment...
...An application for regulatory approval will be submitted in the autumn, said Pfizer, which is hunting for new ways to boost revenues as sales of Covid-19 vaccines begin to moderate....
...US drug regulators have approved applications by Moderna and BioNTech/Pfizer to release a Covid-19 vaccine that specifically targets the dominant strain of the Omicron coronavirus variant....
...Pfizer and its German partner BioNTech said their application followed FDA guidance to include clinical data from the companies’ previous trials of a bivalent shot developed to target previous Omicron sub...
...Critical fuels, materials and metals for sustainability are essential to power diverse critical technology applications in defence, cleantech, renewable energy, transport, medical and manufacturing sectors...
...Pfizer, which developed its Covid vaccine with German partner BioNTech, delayed an application for emergency authorisation for jabs for pre-school children and younger in February over concerns that a two-dose...
...The postponement of Tuesday’s meeting of external advisers follows an request by the FDA to Pfizer to accelerate its application for authorisation even though initial clinical data suggested two doses of...
...Fluence Labs is, uh, “a decentralized platform designed to enable the freedom of digital innovation via peer-to-peer applications”....
...US officials said on Wednesday the FDA would continue to consider Merck’s approval application....
...The company also expects to submit a complete application to the US Food and Drug Administration by year’s end....
...The FDA declined to comment on Pfizer’s application....
...Triomphe believes the company is well placed to succeed: it bought mRNA start-up Translate Bio for $3bn earlier this year, and has promised to plough €400m a year into mRNA vaccine research with 400 scientists...
International Edition